{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:44:13Z","timestamp":1791042253045,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ahj.2004.07.023","type":"journal-article","created":{"date-parts":[[2005,5,14]],"date-time":"2005-05-14T07:51:38Z","timestamp":1116057098000},"page":"820-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients"],"prefix":"10.1016","volume":"149","author":[{"given":"Emiliana","family":"Ferramosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Chasan-Taber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.ahj.2004.07.023_bib1","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahj.2004.07.023_bib2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/ndt\/15.suppl_5.58","article-title":"Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management","volume":"15","author":"Parfrey","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahj.2004.07.023_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.07.023_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","article-title":"Inflammation in end-stage renal disease: sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ahj.2004.07.023_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.61.s80.18.x","article-title":"Inflammation and cardiovascular risk in dialysis patients","volume":"80","author":"Wanner","year":"2002","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ahj.2004.07.023_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.07.023_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1755.1998.00032.x","article-title":"C-reactive protein as an outcome predictor for maintenance hemodialysis patients","volume":"54","author":"Owen","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib9","first-page":"287","article-title":"Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease","volume":"48","author":"Undas","year":"2002","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ahj.2004.07.023_bib10","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2004.07.023_bib11","first-page":"238","article-title":"Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL","volume":"16","author":"van den Akker","year":"2003","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","article-title":"HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients","volume":"61","author":"Seliger","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahj.2004.07.023_bib14","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","article-title":"The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease","volume":"13","author":"De Boer","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib16","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahj.2004.07.023_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ahj.2004.07.023_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2004.07.023_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiology.208.3.9722864","article-title":"Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method","volume":"208","author":"Callister","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.ahj.2004.07.023_bib20","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1525-139X.2003.16028.x","article-title":"Traditional cardiac risk factors in individuals with chronic kidney disease","volume":"16","author":"Uhlig","year":"2003","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ahj.2004.07.023_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease","volume":"15","author":"Mallamaci","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease","volume":"10","author":"Kielstein","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","article-title":"Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease","volume":"97","author":"Moustapha","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.07.023_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","article-title":"Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure","volume":"109","author":"Scholze","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.07.023_bib26","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/01.CIR.0000038946.91899.BB","article-title":"Choices for Healthy Outcomes in Caring for ESRD. Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE study","volume":"106","author":"Longenecker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.07.023_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahj.2004.07.023_bib28","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","article-title":"Impact of aortic stiffness on survival in end-stage renal disease","volume":"99","author":"Blacher","year":"1999","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.ahj.2004.07.023_bib29","first-page":"S1","article-title":"Clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahj.2004.07.023_bib30","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ahj.2004.07.023_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahj.2004.07.023_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib33","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1046\/j.1523-1755.1999.07318.x","article-title":"Histological diagnosis of renal osteodystrophy","volume":"56","author":"Freemont","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahj.2004.07.023_bib35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahj.2004.07.023_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1523-1755.2002.00459.x","article-title":"Bile acid binding to sevelamer HCl","volume":"62","author":"Braunlin","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ahj.2004.07.023_bib37","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.279.24.1955","article-title":"Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease","volume":"279","author":"Lamarche","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.07.023_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.101.5.477","article-title":"Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS)","volume":"101","author":"Gotto","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.07.023_bib39","first-page":"A40","article-title":"Triglyceride-rich lipoproteins and progression of atherosclerosis","volume":"19","author":"Hodis","year":"1998","journal-title":"Eur. Heart J."},{"issue":"4, Suppl. 1","key":"10.1016\/j.ahj.2004.07.023_bib40","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/ajkd.2001.27384","article-title":"Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease","volume":"38","author":"Quaschning","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahj.2004.07.023_bib41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.V971277","article-title":"Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients","volume":"9","author":"Shoji","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ahj.2004.07.023_bib42","first-page":"206A","article-title":"Sevelamer hydrochloride (Renagel) adsorbs the uremic compound indoxyl sulfate","volume":"14","author":"De Smet","year":"2003","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304004594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304004594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:14:46Z","timestamp":1757567686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304004594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0002870304004594"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.07.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}